paxilline has been researched along with Ovarian Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Z; Jiang, S; Liu, L; Sun, Y; Wu, Q; Xia, H; You, Y | 1 |
| Bach, DH; Bayraktar, E; Cho, MS; Choi, HJ; Dasari, SK; Ivan, C; Kim, MS; Lopez-Berestein, G; Mangala, LS; Noh, K; Pradeep, S; Rodriguez-Aguayo, C; Sood, AK; Stur, E; Wu, SY | 1 |
| Al-aidaroos, AQ; Guo, K; Li, J; Liu, H; Wang, H; Zeng, Q; Zhang, HF | 1 |
| Albitar, L; Aponte, M; Cramer, DW; Edwards, D; Jiang, W; Lakkis, M; Li, MJ; Mok, SC; Vitonis, A; Ye, B | 1 |
| Deng, B; Han, Z; Miao, Y; Wen, F; Zhang, S; Zhang, X; Zhang, Y | 1 |
| Ikebuchi, Y; Kawagishi, R; Morishige, K; Murata, Y; Sawada, K; Tahara, M; Tasaka, K | 1 |
| Ikebuchi, Y; Kawagishi, R; Morishige, Ki; Murata, Y; Sawada, K; Tahara, M; Tasaka, K | 1 |
| Cheng, W; Liu, J; Montell, DJ; Naora, H; Silver, DL | 1 |
| French, R; Nguyen, GH; Radhakrishna, H | 1 |
| Hashimoto, K; Morishige, K; Murata, Y; Sakata, M; Sawada, K; Shimizu, S; Tahara, M; Tasaka, K | 1 |
10 other study(ies) available for paxilline and Ovarian Neoplasms
| Article | Year |
|---|---|
Autophagy-related gene PXN as a prognostic marker: Promotion of ovarian cancer progression by suppressing the p110β/Vps34/Beclin1 pathway.
Topics: Apoptosis; Autophagy; Beclin-1; Cell Line, Tumor; Cell Proliferation; Female; Humans; Ovarian Neoplasms; Paxillin; Phosphatidylinositol 3-Kinases; Prognosis; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Nucleus; Cell Proliferation; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Paxillin; Prognosis; src-Family Kinases; Survival Rate; Tissue Plasminogen Activator; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Integrin alpha2; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Ovarian Neoplasms; Paxillin; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-fos; Transplantation, Heterologous; Tumor Burden; Up-Regulation | 2013 |
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
Topics: Cell Line, Tumor; Disease Progression; ErbB Receptors; Female; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Models, Biological; Neoplasm Invasiveness; Ovarian Neoplasms; Paxillin; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Tyrosine | 2008 |
Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin α5β1 and phosphorylating FAK and paxillin.
Topics: Adrenomedullin; Calreticulin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Female; Focal Adhesion Kinase 1; Gene Expression; Humans; Integrin alpha5beta1; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paxillin; Phosphorylation; Prognosis; Signal Transduction | 2012 |
Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.
Topics: Alendronate; Cell Movement; Cell Survival; Cytoskeletal Proteins; Diterpenes; Drug Interactions; Enzyme Activation; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Lysophospholipids; Myosin Light Chains; Ovarian Neoplasms; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; rho GTP-Binding Proteins; Tumor Cells, Cultured; Tyrosine | 2002 |
Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
Topics: Cell Movement; Cytoskeletal Proteins; Enzyme Inhibitors; Female; Focal Adhesions; Humans; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Myosin-Light-Chain Kinase; Myosin-Light-Chain Phosphatase; Ovarian Neoplasms; Paxillin; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Stress Fibers; Tumor Cells, Cultured; Tyrosine | 2002 |
Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility.
Topics: Animals; Cell Movement; Cytoskeletal Proteins; DNA-Binding Proteins; Epithelial Cells; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Humans; Mice; NIH 3T3 Cells; Ovarian Neoplasms; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; STAT3 Transcription Factor; Trans-Activators | 2004 |
Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.
Topics: 1-Methyl-3-isobutylxanthine; Actin Cytoskeleton; Actins; Animals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Proliferation; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Cytoskeletal Proteins; Cytoskeleton; Female; Humans; Lysophospholipids; Ovarian Neoplasms; Paxillin; Phosphoproteins; Serum Response Factor; Tumor Cells, Cultured | 2004 |
Geranylgeranylacetone inhibits lysophosphatidic acid-induced invasion of human ovarian carcinoma cells in vitro.
Topics: Actins; Acute-Phase Proteins; Cell Shape; Cell Survival; Cytoskeletal Proteins; Diterpenes; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Lysophospholipids; Neoplasm Invasiveness; Ovarian Neoplasms; Paxillin; Phosphoproteins; Phosphorylation; Tumor Cells, Cultured | 2005 |